The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
This is the second of two webinars dedicated to presenting and discussing the articles included in the supplement published on Transplant International – Special Issue “Clinical trial design and endpoints in kidney transplantation”. This Special Issue will serve as a guide for the design of future clinical trials aiming at improving outcomes after kidney transplantation.
Transplant nephrologists/surgeons, transplant allied health care professionals, clinical trial nurses and clinical trialists, transplant researchers, representatives of patients societies and patients advocates, representatives of pharmaceutical companies, health authorities
18:00 – 18:05: Executive summary and key messages from the webinar on “Defining rejection”; Maarten Naesens | Leuven, Belgium
18:05 – 18:15: Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation; Luuk Hilbrands | Nijmegen, Netherlands
18:15 – 18:25: Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation; Marlies Reinders | Rotterdam, The Netherlands
18:25 – 18:35: Surrogate Endpoints for Late Kidney Transplantation Failure; Alexandre Loupy | Paris, France
18:35 – 18:45: Patient-reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions; Fabienne Dobbels | Leuven, Belgium
18:45 – 18:50: The patient perspective; Fiona Loud | London, UK
18:50 – 19:00 Q&A and open discussion
Closing remarks: Maria Irene Bellini | Rome, Italy and Stefan Schneeberger | Innsbruck, Austria